CTLA4 and neoplasm: Furthermore, single cell RNA sequencing revealed a high heterogeneity of tumor infiltrating CD8+ T cells in CTCL skin with a strong variation in the expression of co-inhibitory receptors PD1, CTLA4, TIM3, LAG3, and TIGIT (14), which could affect capacity of tumor cell killing.